ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RVP vs PAVM // RSI-14 & 200D SMA MOMENTUM

Retractable Technologies Inc. (NYSE) VS. PAVmed Inc. (NASDAQ) • 15-METRIC TALLY: RVP 7 — PAVM 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PAVM
rsi-technicals
26.5
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVP VS. PAVM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RVP PAVM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 0.10% -30.00% +30.10 RVP /gross-margins <GO>
Return on Invested Capital (ROIC) -23.30% -35.00% +11.70 RVP /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -55.30% -60.00% +4.70 RVP /operating-margins <GO>
Net Profit Margin -32.80% -60.00% +27.20 RVP /net-margins <GO>
Revenue Growth (YoY) 15.80% -65.00% +80.80 RVP /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.52 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 RVP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 22.7 26.5 -3.80 PAVM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $17.3M $15.8M $1.5M RVP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RVP REV PAVM REV RVP GROSS % PAVM GROSS % RVP FCF PAVM FCF
FY 2025 $38.3M $71.0K 0.1% -50.0% -$7.1M -$5.2M
FY 2024 $33.0M $3.0M -3.1% -50.0% -$13.0M -$33.6M
FY 2023 $43.6M $2.5M — — $2.8M -$52.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVP // BETA —
PAVM // BETA —